title: Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation.
authors.affiliation: Savonlinna Central Hospital, Finland.
authors.forename: Aarne
authors.initials: A
authors.lastname: Vartia
authors.forename: Markku R
authors.initials: MR
authors.lastname: Asola
authors.forename: Risto
authors.initials: R
authors.lastname: Tertti
authors.forename: Pertti
authors.initials: P
authors.lastname: Kunelius
authors.forename: Kaj P
authors.initials: KP
authors.lastname: Metsärinne
mesh_terms: D000368:Aged; D003928:Diabetic Nephropathies / Q000628:therapy; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D006435:Renal Dialysis
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa